A recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein. Produced in CHO cell culture.
Figure 1 Trastuzumab (TP-083CL) in SPR
SPR assays of TP-083CL.
The affinity of Trastuzumab (TP-083CL) was determined by SPR.
Captured TP-083CL on CM5 Chip via Anti-Human IgG (Fc) can bind Human ERBB2 protein with an affinity constant of 1.45 nM as determined in a SPR assay (Biacore 8K).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
|MOB-1117z||Mouse Anti-IGHG1 Recombinant Antibody (clone 5C2)||FC, IF, IHC, WB||Mouse IgG1, κ|
|MOB-034LC||Mouse Anti-IGHG1 Recombinant Antibody (clone YC121)||ELISA, WB, IHC||Mouse IgG|
|MOR-1394||Rabbit Anti-IGHG1 Recombinant Antibody (clone DS1394AB)||ICC, IHC, FC, ELISA||Rabbit IgG|
|MOR-1771||Rabbit Anti-IGHG1 Recombinant Antibody (clone DS1771AB), PE||FC||Rabbit IgG|
|EPAF-0577CQ||Mouse Anti-IGHG1 Recombinant Antibody (clone B3-18)||ELISA||Mouse IgM|
There are currently no Customer reviews or questions for TP-083CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.